Similar articles

• Aspirin for prevention of stroke and cardiovascular events among patients with peripheral artery disease.

  Takagi H, Umemoto T. Takagi H, et al. JAMA. 2009 Sep 16;302(11):1165; author reply 1165-6. doi: 10.1001/jama.2009.1325. JAMA. 2009. PMID: 19755690 No abstract available.
• Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.

  Wong S, Morel-Kopp MC, Chen Q, Appleberg M, Ward CM, Lewis DR. Wong S, et al. Thromb Haemost. 2006 Jun;95(6):1042-3. doi: 10.1160/TH05-12-0808. Thromb Haemost. 2006. PMID: 16732389 Clinical Trial. No abstract available.
• Prevention of vascular events in diabetes mellitus: which "antithrombotic" therapy?

  Ceriello A, Motz E. Ceriello A, et al. Diabetologia. 1996 Nov;39(11):1405-6. doi: 10.1007/s001250050591. Diabetologia. 1996. PMID: 8933013 No abstract available.
• Diabetes mellitus and peripheral vascular disease: is aspirin effective in preventing vascular events?

  Cimminiello C, Milani M. Cimminiello C, et al. Diabetologia. 1996 Nov;39(11):1402-4. doi: 10.1007/s001250050590. Diabetologia. 1996. PMID: 8933012 Review. No abstract available.
• Antiplatelet and antithrombotic treatment of patients with peripheral arterial disease.

  Poredos P, Jezovnik MK. Poredos P, et al. Int Angiol. 2010 Feb;29(1):20-6. Int Angiol. 2010. PMID: 20224527 Review.